Filing search / Context Therapeutics Inc. / "Bonus" / Page 2

POS AM

3v2ufh0

4 Apr 22

Prospectus update (post-effective amendment)

5:08pm

DEF 14A

krnbwy1o

4 Apr 22

Definitive proxy

4:10pm

10-K

EX-10.17

ux565dgm

23 Mar 22

Annual report

4:17pm

424B4

rakmy8wmivox5fyq

17 Dec 21

Prospectus supplement with pricing info

8:00am

8-K

gldof0ngua5ctz u0k

1 Nov 21

Context Therapeutics® Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Legal Officer

4:03pm

8-K

EX-10.1

1r9jgng586z

1 Nov 21

Context Therapeutics® Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Legal Officer

4:03pm

8-K

EX-10.1

yeokr sckjnjlq4i9t

22 Oct 21

Departure of Directors or Certain Officers

4:28pm

8-K

ubtq2hmz1z8 3io00s

22 Oct 21

Departure of Directors or Certain Officers

4:28pm

8-K

EX-3.2

ghimj36k s1c

22 Oct 21

Departure of Directors or Certain Officers

4:28pm

424B4

j45x65j3dhl4sna 332

20 Oct 21

Prospectus supplement with pricing info

5:05pm

S-1

xfyir47 yf

27 May 21

IPO registration

5:28pm